£50m dementia bid launched


Sign up online today & collaborate

or click here to find out more

£50m dementia bid launched


Date: 02/06/2015

The £50 million project - led by the University - brings together scientists from across Europe.

They will collaborate to identify people at high risk of developing Alzheimer’s disease.

Participants will be invited to take part in drug trials and to adopt lifestyle changes that could slow onset of the condition.

The researchers’ goal is to improve understanding and management of Alzheimer’s disease in people with very early symptoms or none.

Previous attempts to bring new drugs for Alzheimer’s disease to the market have proved unsuccessful despite high levels of investment.

Research is now focusing on prevention in the hope that early intervention can be a more effective approach to managing the condition.

Alzheimer’s disease is a progressive disorder. Early warning signs of the condition can be identified for up to twenty years before a person develops symptoms.

This latest initiative will establish a European-wide register of 24,000 people deemed at high risk of developing dementia.

Scientists hope that by identifying biomarkers - molecules in tissue or blood that indicate disease - they will detect people with early stage dementia even if they have no noticeable symptoms.

For more click here

Source: Roslin Biocentre

© Catalyst Innovation Portal 2019